Geopolitical Flare-up and GLP-1 Headwinds Greet Weekend Markets remain closed for the weekend, but news flow continues to challenge the week's bullish momentum. Russia's massive overnight missile and drone barrage across Ukraine adds a fresh layer of geopolitical risk, potentially bolstering safe-haven demand in the coming session, reflected in early moves in GDX and USO.
Separately, LLY $884.02 faces renewed scrutiny as its new obesity drug, Foundayo, reports slower-than-expected initial prescription uptake. The entry of AMZN $263.96 into the clinical pharmacy space further intensifies competition in the GLP-1 market, putting pressure on LLY $884.02's valuation following its multiyear rally.
